Drug intelligence / Profile preview

Gencure-Fem

Development stage
Unknown
Lead developer
Gynogen
Modality
Small Molecules
Administration
Oral
01

Overview

Gencure-Fem is a specialized combination fertility supplement and ovulatory stimulant marketed by Gynogen (a division of Kabir Lifesciences). It is supplied as a combi pack containing clomifene citrate and acetylcysteine tablets, alongside astaxanthin capsules. Clomifene citrate is a selective estrogen receptor modulator (SERM) that stimulates ovulation by inhibiting estrogen receptors in the hypothalamus, thereby increasing the release of gonadotropins (follicle-stimulating hormone and luteinizing hormone). Acetylcysteine acts as an antioxidant and glutathione precursor to improve insulin sensitivity and reduce oxidative stress, while astaxanthin provides additional potent antioxidant protection to support oocyte quality and overall reproductive health. Gencure-Fem is primarily indicated for the management of female infertility, particularly in women with ovulatory disorders such as polycystic ovary syndrome (PCOS) or unexplained infertility.

Brand names
Gencure-Fem
Other names
Gencure FemGencure-Fem Combi Pack
02

Targets

ESR1 (ERα)ESR2 (ERβ)

Beyond the preview

Go deeper on Gencure-Fem.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gencure-Fem.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call